242 related articles for article (PubMed ID: 16957888)
21. Cyclosporin A in the treatment of adult onset Still's disease.
Marchesoni A; Ceravolo GP; Battafarano N; Rossetti A; Tosi S; Fantini F
J Rheumatol; 1997 Aug; 24(8):1582-7. PubMed ID: 9263155
[TBL] [Abstract][Full Text] [Related]
22. Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease.
Banse C; Vittecoq O; Benhamou Y; Gauthier-Prieur M; Lequerré T; Lévesque H
Joint Bone Spine; 2013 Dec; 80(6):653-5. PubMed ID: 23751410
[TBL] [Abstract][Full Text] [Related]
23. Adult onset still's disease with autoimmune haemolytic anaemia: two rarities in combination.
Ishaq M; Mohammad JS; Naqvi SA; Shaikh MI
J Pak Med Assoc; 2011 Dec; 61(12):1239-41. PubMed ID: 22355977
[TBL] [Abstract][Full Text] [Related]
24. Cardiac magnetic resonance in myocarditis from adult onset Still's disease successfully treated with anakinra.
Choi AD; Moles V; Fuisz A; Weissman G
Int J Cardiol; 2014; 172(1):e225-7. PubMed ID: 24461482
[No Abstract] [Full Text] [Related]
25. Cerebral haemorrhage complicating adult-onset Still's disease: a case report.
Kurabayashi H; Kubota K; Tamura K; Shirakura T
J Int Med Res; 1996; 24(6):492-4. PubMed ID: 8959535
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary arterial hypertension in adult onset Still's disease: a case report of a severe complication.
Guilleminault L; Laurent S; Foucher A; Poubeau P; Paganin F
BMC Pulm Med; 2016 May; 16(1):72. PubMed ID: 27160441
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous polyarteritis nodosa in adult onset Still's disease.
Mylona E; Vadala C; Papadakos V; Loverdos D; Samarkos M; Skoutelis A
Eur J Dermatol; 2009; 19(6):621-2. PubMed ID: 19592325
[TBL] [Abstract][Full Text] [Related]
28. Refractory adult onset Still's disease successfully treated with anakinra.
Vasques Godinho FM; Parreira Santos MJ; Canas da Silva J
Ann Rheum Dis; 2005 Apr; 64(4):647-8. PubMed ID: 15374853
[No Abstract] [Full Text] [Related]
29. Steroid-sparing effects of etanercept in a patient with steroid-dependent adult-onset Still's disease.
Kiyonaga Y; Maeshima K; Imada C; Haranaka M; Ishii K; Shibata H
Intern Med; 2014; 53(11):1209-13. PubMed ID: 24881751
[TBL] [Abstract][Full Text] [Related]
30. Listeria monocytogenes meningitis in a patient receiving etanercept for Still's disease.
La Montagna G; Valentini G
Clin Exp Rheumatol; 2005; 23(1):121. PubMed ID: 15789900
[No Abstract] [Full Text] [Related]
31. Adult-onset Still's disease with disseminated intravascular coagulation and hemophagocytic syndrome: a case report.
Mimura T; Shimodaira M; Kibata M; Tsukadaira A; Shirahata K
BMC Res Notes; 2014 Dec; 7():940. PubMed ID: 25532568
[TBL] [Abstract][Full Text] [Related]
32. Adult Still's disease with myocarditis and peritonitis.
Hosaka S; Takashina N; Ishikawa A; Kondo H; Kashiwazaki S
Intern Med; 1992 Jun; 31(6):812-5. PubMed ID: 1392186
[TBL] [Abstract][Full Text] [Related]
33. Chronic myelogenous leukemia that occurred two years after the diagnosis of adult Still's disease.
Nakagawa Y; Furusyo N; Taniai H; Henzan H; Tsuchihashi T; Hayashi J
Intern Med; 2005 Sep; 44(9):994-7. PubMed ID: 16258220
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of refractory adult onset Still's disease with rituximab.
Belfeki N; Smiti Khanfir M; Said F; Hamzaoui A; Ben Salem T; Ben Ghorbel I; Lamloum M; Houman MH
Reumatismo; 2016 Dec; 68(3):159-162. PubMed ID: 27981819
[TBL] [Abstract][Full Text] [Related]
35. Marked effect and steroid-sparing ability of anakinra on a patient with refractory adult-onset Still's disease.
Tamaki H; Shimizu H; Hiraoka E; Uechi E; Kishimoto M; Yamaguchi K; Okada M
Mod Rheumatol; 2010 Apr; 20(2):200-4. PubMed ID: 20037747
[TBL] [Abstract][Full Text] [Related]
36. Successful methotrexate therapy for adult Still's disease with marked thrombocytopenia.
Yamaguchi M; Matsukawa Y; Takahashi N; Takei M; Tomita Y; Nishinarita S; Horie T
Clin Rheumatol; 1998; 17(3):256-7. PubMed ID: 9694066
[TBL] [Abstract][Full Text] [Related]
37. Chronic anemia and thrombocytosis as the initial presentation of Still's disease in an elderly patient.
Vilá LM; Molina MJ
Gerontology; 2007; 53(5):289-92. PubMed ID: 17510560
[TBL] [Abstract][Full Text] [Related]
38. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome.
Kobayashi M; Takahashi Y; Yamashita H; Kaneko H; Mimori A
Mod Rheumatol; 2011 Feb; 21(1):92-6. PubMed ID: 20737186
[TBL] [Abstract][Full Text] [Related]
39. Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?
Efthimiou P; Kontzias A; Ward CM; Ogden NS
Nat Clin Pract Rheumatol; 2007 Jun; 3(6):328-35. PubMed ID: 17538564
[TBL] [Abstract][Full Text] [Related]
40. A SEVERE CASE OF ADULT ONSET STILLS DISEASE WITH MYOPERICARDITIS, RESISTANT TO TREATMENT WITH TOCILIZUMAB BUT RESPONSIVE TO ANAKINRA.
Waghmare S; Valecka B; Cairns AP
Ulster Med J; 2015 May; 84(2):130-2. PubMed ID: 26376493
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
